Therefore, we determined peripheral blood and skeletal muscle gene expression levels of leptin, adiponectin, resistin and visfatin in adult and pediatric patients with DM in comparison to non-disease controls at two different time-points and investigated their relation to clinical parameters and to disease activity measures. The gene discussed is RETN; the disease is dermatomyositis.